FDA grants emergency use authorization Abbott Labs second antibody test

spike

President Donald Trump speaks in the Rose Garden after introducing a new point-of-care COVID-19 test kit developed by Abbott Labs at the White House on March 30, 2020 in Washington, DC.

Win McNamee | Getty Images

The Food and Drug Administration granted emergency use authorization for Abbott Laboratories’ new coronavirus test that detects Covid-19 antibodies, the company announced Monday.

Abbott plans to ship nearly 30 million tests, which can indicate whether a person has had Covid-19 in the past and was either asymptomatic or recovered, in May and will have the capacity to ship 60 million tests in June, the

Read More